Category: Tort Updates

Why Depo-Provera is the Strategic Play for 2025-2026
March 13, 2026 by Mohr Marketing The $3B Liquidity Advantage: Why Depo-Provera is the Strategic Play for 2025-2026 As many mass torts face defendants with thinning capital, the Depo-Provera litigation stands out for its defendant solvency. Pfizer holds massive liquidity, providing the “muscle” to absorb a global settlement without the existential risks seen in other recent litigations. A Mature Docket with… Continue reading Why Depo-Provera is the Strategic Play for 2025-2026
Compliance Shield Depo-Provera Liability Litigation
Why Precision is the Only Way to Build a Depo-Provera Docket
March 12, 2026 by Mohr Marketing Beyond “Intake Noise”: Why Precision is the Only Way to Build a Depo-Provera Docket The pharmaceutical liability landscape has shifted with the emergence of MDL 3140 (In re: Depo-Provera Products Liability Litigation). While the numbers are massive—an estimated 74 million users worldwide—the legal viability of these cases hinges on a level of medical precision that… Continue reading Why Precision is the Only Way to Build a Depo-Provera Docket
Compliance Shield Depo-Provera Liability Litigation
Defendant Solvency and the Business Case for MDL 3140
March 11, 2026 by Mohr Marketing MDL 3140: Is Your Intake Ready for the Depo-Provera Docket? In an era where some mass tort defendants are thinly capitalized or seeking bankruptcy protection, the Depo-Provera litigation offers a rare strategic advantage: Defendant Solvency. Pfizer, the primary defendant, holds massive liquidity, giving them the “muscle” to absorb a global settlement without existential risk to… Continue reading Defendant Solvency and the Business Case for MDL 3140
Compliance Shield Depo-Provera litgation
“Compliance Shield” Protocol for MDL 3084 Rideshare Litigation
February 19, 2026 by Mohr Marketing Mohr Marketing Launches “Compliance Shield” Protocol for MDL 3084 Rideshare Litigation, Solving the “MVA Noise” Crisis for Law Firms As the mass tort landscape pivots following the highly anticipated January 13 start of the MDL 3084 (Rideshare Sexual Assault) bellwether trials, Mohr Marketing, LLC has announced the strategic expansion of its specialized lead generation program.… Continue reading “Compliance Shield” Protocol for MDL 3084 Rideshare Litigation
Compliance Shield Rideshare Lawsuit
Is your intake team vetting for “Addiction” or “Negligence”?
February 12, 2026 by Mohr Marketing Is your intake team vetting for “Addiction” or “Negligence”? There is a massive difference in MDL-3166? The rush for Roblox cases is on. With 70 million daily users, the plaintiff pool is enormous. But if you’ve bought leads recently, you know the reality: The volume is high. The quality is… mixed. Too many firms are… Continue reading Is your intake team vetting for “Addiction” or “Negligence”?
Compliance Shield Roblox Lawsuit
New Standard for Mass Tort and Personal Injury Acquisition
February 10, 2026 by Mohr Marketing Mohr Marketing Launches “Joint Advertising Compliance Program,” Establishing New Integrity Standard for Mass Tort and Personal Injury Acquisition Initiative introduces audit-ready “Chain of Custody” protocols and strict 1-to-1 Consent, directly addressing FRCP Rule 16.1 and rising judicial scrutiny. [Allentown, PA] – [February 9, 2026] – Amidst a landscape of intensifying scrutiny from Multidistrict Litigation (MDL)… Continue reading New Standard for Mass Tort and Personal Injury Acquisition
Compliance Shield Mass Tort Best Practices Mass Tort Lead Generation
MARKET BRIEF: THE 2026 HERNIA MESH PIVOT
January 22, 2026 by Mohr Marketing Allocation Strategy: Bard (MDL 2846) vs. Covidien (MDL 3029) EXECUTIVE SUMMARY The “Hernia Mesh” bucket is no longer a single asset class. As we enter Q1 2026, the litigation has bifurcated into two distinct phases. Bard has transitioned into a mature “Administration & Cleanup” phase, where value is found only in specific, high-damage claims. Covidien,… Continue reading MARKET BRIEF: THE 2026 HERNIA MESH PIVOT
Bard Hernia Mesh Litigation Covidien Litigation
Mohr Marketing Takes A Multi-Layered Approach to Compliance
December 19, 2025 by Mohr Marketing Mohr Marketing Sets New Standard for Mass Tort Intake with Advanced “Compliance Shield” Technology to Combat Lead Fraud As Multidistrict Litigation (MDL) dockets continue to expand, encompassing cases such as Rideshare, Roblox, J&J Talc, Hernia Mesh, and AFFF, Mohr Marketing today announced the deployment of a rigorous, multi-layered compliance program designed to eliminate “fake leads”… Continue reading Mohr Marketing Takes A Multi-Layered Approach to Compliance
Mass Tort Lead Generation MDL Leads
Why Compliance is Mohr Marketing’s Top Priority
December 15, 2025 by Mohr Marketing Mohr Marketing’s Proactive Approach to Lead Gen Compliance Mohr Marketing has announced the deployment of “Compliance Shield,” a compliance program designed for mass tort intake. This program is intended to address lead generation processes for expanding Multidistrict Litigation (MDL) dockets, including active litigations such as Rideshare, Roblox, J&J Talc, Hernia Mesh, and AFFF. The implementation… Continue reading Why Compliance is Mohr Marketing’s Top Priority
Mass Tort Lead Generation MDL Leads
Navigating the MDL Surge: Why Compliance Defines Case Quality
December 6, 2025 by Mohr Marketing Navigating the MDL Surge: How Compliance and Verification Define Quality Case Acquisition The landscape of Multidistrict Litigation (MDL) is expanding rapidly. With massive dockets like J&J Talc (67k+ cases), Hernia Mesh (23k+), and AFFF (15k+) continuing to grow, law firms are facing a critical challenge: how to scale volume without polluting their dockets with fraudulent… Continue reading Navigating the MDL Surge: Why Compliance Defines Case Quality
Compliance Program Mass Tort Lead Generation
Recent Posts
Categories
Archives

Copyright © 1994-2025 Mohr Marketing, LLC. All Rights Reserved.

Secret Link